415 related articles for article (PubMed ID: 18574359)
21. Rethinking the role of opioids in the outpatient management of chronic nonmalignant pain.
Provenzano DA; Viscusi ER
Curr Med Res Opin; 2014 Oct; 30(10):2051-62. PubMed ID: 24809728
[TBL] [Abstract][Full Text] [Related]
22. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study.
Ives TJ; Chelminski PR; Hammett-Stabler CA; Malone RM; Perhac JS; Potisek NM; Shilliday BB; DeWalt DA; Pignone MP
BMC Health Serv Res; 2006 Apr; 6():46. PubMed ID: 16595013
[TBL] [Abstract][Full Text] [Related]
23. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.
Trescot AM; Helm S; Hansen H; Benyamin R; Glaser SE; Adlaka R; Patel S; Manchikanti L
Pain Physician; 2008 Mar; 11(2 Suppl):S5-S62. PubMed ID: 18443640
[TBL] [Abstract][Full Text] [Related]
24. Patient aberrant drug taking behaviors in a large family medicine residency program: a retrospective chart review of screening practices, incidence, and predictors.
Lewis M; Herndon CM; Chibnall JT
J Opioid Manag; 2014; 10(3):169-75. PubMed ID: 24944067
[TBL] [Abstract][Full Text] [Related]
25. Chronic opioid therapy for chronic non-cancer pain: a review and comparison of treatment guidelines.
Cheung CW; Qiu Q; Choi SW; Moore B; Goucke R; Irwin M
Pain Physician; 2014; 17(5):401-14. PubMed ID: 25247898
[TBL] [Abstract][Full Text] [Related]
26. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history.
Michna E; Ross EL; Hynes WL; Nedeljkovic SS; Soumekh S; Janfaza D; Palombi D; Jamison RN
J Pain Symptom Manage; 2004 Sep; 28(3):250-8. PubMed ID: 15336337
[TBL] [Abstract][Full Text] [Related]
27. Risk factor assessment for problematic use of opioids for chronic pain.
Jamison RN; Edwards RR
Clin Neuropsychol; 2013; 27(1):60-80. PubMed ID: 22935011
[TBL] [Abstract][Full Text] [Related]
28. A 10-yr Analysis of Chronic Pelvic Pain and Chronic Opioid Therapy in the Women Veteran Population.
Cichowski SB; Rogers RG; Komesu Y; Murata E; Qualls C; Murata A; Murata G
Mil Med; 2018 Nov; 183(11-12):e635-e640. PubMed ID: 29788455
[TBL] [Abstract][Full Text] [Related]
29. Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers?
Edlund MJ; Sullivan M; Steffick D; Harris KM; Wells KB
Pain Med; 2007; 8(8):647-56. PubMed ID: 18028043
[TBL] [Abstract][Full Text] [Related]
30. Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients.
Manchikanti L; Giordano J; Boswell MV; Fellows B; Manchukonda R; Pampati V
J Opioid Manag; 2007; 3(2):89-100. PubMed ID: 17520988
[TBL] [Abstract][Full Text] [Related]
31. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
32. Incidence of iatrogenic opioid dependence or abuse in patients with pain who were exposed to opioid analgesic therapy: a systematic review and meta-analysis.
Higgins C; Smith BH; Matthews K
Br J Anaesth; 2018 Jun; 120(6):1335-1344. PubMed ID: 29793599
[TBL] [Abstract][Full Text] [Related]
33. Aberrant behaviors with prescription opioids and problem drug use history in a community-based cohort of HIV-infected individuals.
Hansen L; Penko J; Guzman D; Bangsberg DR; Miaskowski C; Kushel MB
J Pain Symptom Manage; 2011 Dec; 42(6):893-902. PubMed ID: 21802896
[TBL] [Abstract][Full Text] [Related]
34. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors.
Gupta A; Patton C; Diskina D; Cheatle M
Pain Physician; 2011; 14(4):383-9. PubMed ID: 21785482
[TBL] [Abstract][Full Text] [Related]
35. Long-term neuropsychological effects of opioid use in children: a descriptive literature review.
Jain G; Mahendra V; Singhal S; Dzara K; Pilla TR; Manworren R; Kaye AD
Pain Physician; 2014; 17(2):109-18. PubMed ID: 24658471
[TBL] [Abstract][Full Text] [Related]
36. Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM).
Meltzer EC; Rybin D; Saitz R; Samet JH; Schwartz SL; Butler SF; Liebschutz JM
Pain; 2011 Feb; 152(2):397-402. PubMed ID: 21177035
[TBL] [Abstract][Full Text] [Related]
37. Predictors of resolution of aberrant drug behavior in chronic pain patients treated in a structured opioid risk management program.
Meghani SH; Wiedemer NL; Becker WC; Gracely EJ; Gallagher RM
Pain Med; 2009; 10(5):858-65. PubMed ID: 19523029
[TBL] [Abstract][Full Text] [Related]
38. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction.
Martell BA; O'Connor PG; Kerns RD; Becker WC; Morales KH; Kosten TR; Fiellin DA
Ann Intern Med; 2007 Jan; 146(2):116-27. PubMed ID: 17227935
[TBL] [Abstract][Full Text] [Related]
39. The role of abuse-deterrent formulations in countering opioid misuse and abuse.
Nguyen V; Raffa RB; Taylor R; Pergolizzi JV
J Clin Pharm Ther; 2015 Dec; 40(6):629-34. PubMed ID: 26595258
[TBL] [Abstract][Full Text] [Related]
40. The Effects of Substance Misuse on Auditory and Vestibular Function: A Systematic Review.
Chiao A; Hughes ML; Karimuddanahalli Premkumar P; Zoucha K
Ear Hear; 2024 Mar-Apr 01; 45(2):276-296. PubMed ID: 37784231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
